Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat

Stock Track02-20

Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.

The medical technology company reported an adjusted loss of 26 cents per share for the quarter ended December 31, better than the 31-cent loss analysts had expected. Revenue also exceeded forecasts at $264,000 compared to the $250,000 estimate. However, the company still reported a substantial quarterly loss of $17.43 million.

The stock had surged 82.7% during the quarter leading up to the earnings release, suggesting investors may be engaging in profit-taking despite the positive earnings surprise. While analysts maintain a "strong buy" rating with a median price target of $26, the market reaction indicates concerns about the company's continued losses even as it beats expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192854199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 22:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192854199","market":"us","top_or_hot":-1,"title":"Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat","media":"Stock Track","content":"<p>Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.</p><p>The medical technology company reported an adjusted loss of 26 cents per share for the quarter ended December 31, better than the 31-cent loss analysts had expected. Revenue also exceeded forecasts at $264,000 compared to the $250,000 estimate. However, the company still reported a substantial quarterly loss of $17.43 million.</p><p>The stock had surged 82.7% during the quarter leading up to the earnings release, suggesting investors may be engaging in profit-taking despite the positive earnings surprise. While analysts maintain a \"strong buy\" rating with a median price target of $26, the market reaction indicates concerns about the company's continued losses even as it beats expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.</p><p>The medical technology company reported an adjusted loss of 26 cents per share for the quarter ended December 31, better than the 31-cent loss analysts had expected. Revenue also exceeded forecasts at $264,000 compared to the $250,000 estimate. However, the company still reported a substantial quarterly loss of $17.43 million.</p><p>The stock had surged 82.7% during the quarter leading up to the earnings release, suggesting investors may be engaging in profit-taking despite the positive earnings surprise. While analysts maintain a \"strong buy\" rating with a median price target of $26, the market reaction indicates concerns about the company's continued losses even as it beats expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLSE","symbol_name":"Pulse Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1192854199","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192854199","pubTimestamp":1771597955,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.The medical technology...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PLSE":"Pulse Biosciences, Inc."},"translate_title":"个股追踪|Pulse Biosciences盘中暴跌5.06%尽管盈利超预期但季度强劲上涨后获利了结","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLSE":1},"content_text":"Pulse Biosciences stock plummeted 5.06% during intraday trading on Friday, marking a sharp reversal after the company reported quarterly results that beat analyst expectations.The medical technology company reported an adjusted loss of 26 cents per share for the quarter ended December 31, better than the 31-cent loss analysts had expected. Revenue also exceeded forecasts at $264,000 compared to the $250,000 estimate. However, the company still reported a substantial quarterly loss of $17.43 million.The stock had surged 82.7% during the quarter leading up to the earnings release, suggesting investors may be engaging in profit-taking despite the positive earnings surprise. While analysts maintain a \"strong buy\" rating with a median price target of $26, the market reaction indicates concerns about the company's continued losses even as it beats expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192854199","isCrawlerRequest":true}